Literature DB >> 7775197

Immunohistochemical demonstration of the carbonic anhydrase isoenzymes I and II in pancreatic tumours.

S Parkkila1, A K Parkkila, T Juvonen, V P Lehto, H Rajaniemi.   

Abstract

The location of carbonic anhydrase (CA) isoenzymes I, II and VI in normal and neoplastic pancreatic tissue was studied using polyclonal antisera and the immunoperoxidase technique. Samples were obtained from patients with well-differentiated (n = 4), moderately differentiated (n = 1) and poorly differentiated (n = 4) ductal adenocarcinomas, cystadenocarcinoma (n = 2), adenosquamous carcinoma (n = 1), acinar adenocarcinoma (n = 1), gastrinoma (n = 3), insulinoma (n = 3) and glucagonoma (n = 1). The control specimens were from a patient with traumatic laceration of the pancreas. The normal and malignant endocrine tissue showed intense positive staining for CA I localized in the cells expressing glucagon. In the exocrine pancreatic tissue, CA II was detected in the normal and neoplastic ductal epithelium. No specific staining was detected with anti-CA VI serum in either normal or malignant tissue.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7775197     DOI: 10.1007/bf00243908

Source DB:  PubMed          Journal:  Histochem J        ISSN: 0018-2214


  15 in total

1.  Immunohistochemical localization of human carbonic anhydrase isoenzyme C.

Authors:  T Kumpulainen
Journal:  Histochemistry       Date:  1979-08

2.  A novel carbonic anhydrase from the ovine parotid gland.

Authors:  R T Fernley; R D Wright; J P Coghlan
Journal:  FEBS Lett       Date:  1979-09-15       Impact factor: 4.124

Review 3.  Carbonic anhydrase: isoenzymes, properties, distribution, and functional significance.

Authors:  M J Carter
Journal:  Biol Rev Camb Philos Soc       Date:  1972-11

4.  Cell lineage markers in human pancreatic cancer.

Authors:  J H Kim; S B Ho; C K Montgomery; Y S Kim
Journal:  Cancer       Date:  1990-11-15       Impact factor: 6.860

5.  Competitive time-resolved immunofluorometric assay for quantifying carbonic anhydrase VI in saliva.

Authors:  S Parkkila; A K Parkkila; T Vierjoki; T Ståhlberg; H Rajaniemi
Journal:  Clin Chem       Date:  1993-10       Impact factor: 8.327

6.  Immunohistochemical localization of human carbonic anhydrase isozymes.

Authors:  T Kumpulainen
Journal:  Ann N Y Acad Sci       Date:  1984       Impact factor: 5.691

7.  Immunohistochemical localization of carbonic anhydrase isoenzymes in the human pancreas.

Authors:  T Kumpulainen; P Jalovaara
Journal:  Gastroenterology       Date:  1981-04       Impact factor: 22.682

8.  Distribution of the carbonic anhydrase isoenzymes I, II, and VI in the human alimentary tract.

Authors:  S Parkkila; A K Parkkila; T Juvonen; H Rajaniemi
Journal:  Gut       Date:  1994-05       Impact factor: 23.059

9.  Immunocytochemical demonstration of carbonic anhydrase in human epithelial cells.

Authors:  S S Spicer; M A Sens; R E Tashian
Journal:  J Histochem Cytochem       Date:  1982-09       Impact factor: 2.479

10.  Mitochondrial carbonic anhydrase.

Authors:  S J Dodgson; R E Forster; B T Storey; L Mela
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

View more
  10 in total

1.  The role of carbonic anhydrases in tumors.

Authors:  A Nógrádi
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

2.  Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro.

Authors:  S Parkkila; H Rajaniemi; A K Parkkila; J Kivela; A Waheed; S Pastorekova; J Pastorek; W S Sly
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

3.  Expression of testosterone-dependent enzyme, carbonic anhydrase III, and oxidative stress in experimental alcoholic liver disease.

Authors:  S Parkkila; C H Halsted; J A Villanueva; H K Väänänen; O Niemelä
Journal:  Dig Dis Sci       Date:  1999-11       Impact factor: 3.199

4.  The cyclooxygenase-2 inhibitor celecoxib is a potent inhibitor of human carbonic anhydrase II.

Authors:  James F Knudsen; Uno Carlsson; Per Hammarström; Gerald H Sokol; Louis R Cantilena
Journal:  Inflammation       Date:  2004-10       Impact factor: 4.092

5.  Carbonic anhydrase II in the endothelium of glial tumors: a potential target for therapy.

Authors:  Joonas Haapasalo; Kristiina Nordfors; Sally Järvelä; Helena Bragge; Immo Rantala; Anna-Kaisa Parkkila; Hannu Haapasalo; Seppo Parkkila
Journal:  Neuro Oncol       Date:  2007-04-13       Impact factor: 12.300

6.  Immunohistochemical demonstration of human carbonic anhydrase isoenzyme II in brain tumours.

Authors:  A K Parkkila; R Herva; S Parkkila; H Rajaniemi
Journal:  Histochem J       Date:  1995-12

Review 7.  Carbonic anhydrases in normal gastrointestinal tract and gastrointestinal tumours.

Authors:  Antti-J Kivelä; Jyrki Kivelä; Juha Saarnio; Seppo Parkkila
Journal:  World J Gastroenterol       Date:  2005-01-14       Impact factor: 5.742

8.  Enhancing the Anticancer Potential of Targeting Tumor-Associated Metalloenzymes via VEGFR Inhibition by New Triazolo[4,3-a]pyrimidinone Acyclo C-Nucleosides Multitarget Agents.

Authors:  Mohamed Nabil Abd Al Moaty; El Sayed Helmy El Ashry; Laila Fathy Awad; Nihal Ahmed Ibrahim; Marwa Muhammad Abu-Serie; Assem Barakat; Mezna Saleh Altowyan; Mohamed Teleb
Journal:  Molecules       Date:  2022-04-08       Impact factor: 4.927

9.  The Role and Underlying Mechanism of Exosomal CA1 in Chemotherapy Resistance in Diffuse Large B Cell Lymphoma.

Authors:  Yuhua Feng; Meizuo Zhong; Youhong Tang; Xianling Liu; Yiping Liu; Leyuan Wang; Hui Zhou
Journal:  Mol Ther Nucleic Acids       Date:  2020-06-24       Impact factor: 8.886

10.  Antiproliferative and Carbonic Anhydrase II Inhibitory Potential of Chemical Constituents from Lycium shawii and Aloe vera: Evidence from In Silico Target Fishing and In Vitro Testing.

Authors:  Najeeb Ur Rehman; Sobia Ahsan Halim; Majid Khan; Hidayat Hussain; Husain Yar Khan; Ajmal Khan; Ghulam Abbas; Kashif Rafiq; Ahmed Al-Harrasi
Journal:  Pharmaceuticals (Basel)       Date:  2020-05-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.